Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 10,700 shares, a decline of 37.4% from the November 15th total of 17,100 shares. Based on an average daily trading volume, of 8,600 shares, the short-interest ratio is currently 1.2 days.
Core One Labs Stock Down 2.6 %
OTCMKTS:CLABF traded down $0.02 on Thursday, reaching $0.64. 1,286 shares of the company's stock were exchanged, compared to its average volume of 15,322. The business has a fifty day moving average of $0.64 and a 200-day moving average of $0.45. Core One Labs has a 52-week low of $0.22 and a 52-week high of $1.81.
Get Core One Labs alerts:About Core One Labs
(Get Rating)
Core One Labs Inc operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents.Further Reading
- Get a free copy of the StockNews.com research report on Core One Labs (CLABF)
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
- Inflation and the Energy Crisis are Two Freight Trains on a Collision Course – Here's How to Prepare
- Is Enterprise Products Partners Fairly Valued?
- Will WhatsApp Partnership Boost MercadoLibre's Earnings?
Receive News & Ratings for Core One Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core One Labs and related companies with MarketBeat.com's FREE daily email newsletter.